Dare Bioscience, Inc. Other Receivables
Dare Bioscience, Inc. (DARE) had Other Receivables of $400.00 thousand as of 2025-12-31, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Nontrade Receivables
us-gaap:OtherReceivables · last filed 2026-08-13
- 2025-12-31: Other Receivables $400.00K.
| Period end | Other Receivables |
|---|---|
| 2025-12-31 | $400.00K 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |